Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease

Background: “On-demand” treatments approved in the United States (US) for “OFF” episodes in Parkinson’s disease (PD) include apomorphine hydrochloride injection (SC-APO), apomorphine sublingual film (APL), and levodopa inhalation powder (CVT-301). APL received US approval in 2020, and its cost-effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Thach, Andrew, Kirson, Noam, Zichlin, Miriam L., Dieye, Ibrahima, Pappert, Eric, Williams, G. Rhys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2021
Materias:
Neurological Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809356/
https://www.ncbi.nlm.nih.gov/pubmed/35178465
http://dx.doi.org/10.36469/jheor.2021.29488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809356/
https://www.ncbi.nlm.nih.gov/pubmed/35178465
http://dx.doi.org/10.36469/jheor.2021.29488

Ejemplares similares